Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by JAN KEMNADE and DAVID HERNANDEZ.
JAN KEMNADE
Connection Strength
0.588
DAVID HERNANDEZ
  1. Phase I / II trial of metformin as a chemo-radiosensitizer in a head and neck cancer patient population. Oral Oncol. 2023 10; 145:106536.
    View in: PubMed
    Score: 0.228
  2. Consistent multimodality approach to oral cavity and high-risk oropharyngeal cancer in veterans. Am J Otolaryngol. 2021 Nov-Dec; 42(6):103166.
    View in: PubMed
    Score: 0.198
  3. Deployment of cisplatin in Veterans with oropharyngeal cancer: toxicity and impact on oncologic outcomes. Laryngoscope Investig Otolaryngol. 2023 Aug; 8(4):895-902.
    View in: PubMed
    Score: 0.057
  4. Persistent ethnicity-associated disparity in anti-tumor effectiveness of immune checkpoint inhibitors despite equal access. Cancer Res Commun. 2022 07 26; 2022.
    View in: PubMed
    Score: 0.053
  5. Oropharyngeal cancer outcomes correlate with p16 status, multinucleation and immune infiltration. Mod Pathol. 2022 08; 35(8):1045-1054.
    View in: PubMed
    Score: 0.052
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.